YORHAVYN
"YORHAVYN" is a word mark owned by CSL Behring GmbH, filed at the USPTO on February 2, 2023. It is registered and covers class 5 (Pharmaceuticals).
- Status
- Registered
- Since August 5, 2025
- Filed
- February 2, 2023
- Registered
- August 5, 2025
- Priority date
- January 12, 2023
- Claimed from European Union
- Application no.
- 97777748
- Registration no.
- 7877491
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 1 class
Who owns YORHAVYN
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
CSL Behring GmbH
Marburg, Germany
Representative
Scott D. Woldow
Smith, Gambrell & Russell, LLP
What the mark covers
The products and services YORHAVYN is filed for, grouped by Nice class.
Pharmaceutical preparations for treating von Willebrand disease, hemophilia, primary immunodeficiency, hereditary angioedema, fibrinogen deficiency, Alpha 1 antitrypsin deficiency, and inflammatory demyelinating polyneuropathy; blood plasma; blood plasma fractions; recombinant protein arrays for medical diagnosis purposes in the hematology field; Pharmaceutical preparations for the treatment and prevention of blood and bleeding disorders; blood products for the treatment of hemophilia, namely, pharmaceutical preparations for the treatment of hemophilia; pharmaceutical products derived from recombinant DNA technology for the treatment of hemophilia, namely, pharmaceutical preparations derived from recombinant DNA technology for the treatment of hemophilia; blood products for the treatment of hemophilia, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; pharmaceutical preparations and substances for the treatment of blood disorders; antibodies, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing in the hematology field; blood for medical purposes; cell cultures for medical purposes, namely, cells for medical or clinical use in the hematology field; cell cultures for medical purposes, namely, living cells for medical use in the hematology field; cell cultures for medical purposes, namely, stem cells for medical or veterinary use in the hematology field; pharmaceutical preparations for the treatment of blood conditions, respiratory conditions, pneumonia, covid-19, and influenza; Pharmaceutical preparations, namely, antibody for the treatment of acute respiratory distress syndrome, ARDS; pharmaceutical preparations, namely, antibody for the treatment of Idiopathic Pulmonary Fibrosis, IPF and Interstitial Lung Diseases, ILD; Pharmaceutical preparations, namely, antibody for the treatment of Hereditary Angioedema, HAE
What has happened so far
Steps recorded by the USPTO, newest first.
- Notice of registration confirmation emailed
- Registered-principal register
- Ttab release case to trademarks
- Opposition terminated no. 999999
- Opposition dismissed no. 999999
- Extension of time to oppose process - terminated
- Opposition instituted no. 999999
- Extension of time to oppose received
- Official gazette publication confirmation e-mailed
- Published for opposition
10 earlier steps on the official record.
Oppositions and cancellations
Proceedings recorded against this mark by the USPTO. Reported as recorded, not legal advice.
About YORHAVYN
Who owns the trademark "YORHAVYN"?
The USPTO trademark "YORHAVYN" (application 97777748) is owned by CSL Behring GmbH.
What is the status of "YORHAVYN"?
Its status at the USPTO is: registered.
When was "YORHAVYN" registered?
It was registered on August 5, 2025.
Get this data via the API
Everything on this page comes from the Signa API. Pull YORHAVYN and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2b56-f084-7629-9119-525bf0fde3e6
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2b56-f084-7629-9119-525bf0fde3e6",
"object": "trademark",
"mark_text": "YORHAVYN",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "US",
"application_number": "97777748",
"filing_date": "2023-02-02",
"nice_classes": [
5
],
"owners": [
{
"name": "CSL Behring GmbH",
"entity_id": "ent_019eb6f7-2013-757e-9375-c0720a3cb498"
}
]
}